France is sticking to its plan to offer over-55s the Johnson & Johnson vaccine suspended within the US and South Africa over uncommon blood clots, a authorities spokesman mentioned Wednesday.
Gabriel Attal additionally reaffirmed the federal government’s confidence within the AstraZeneca jab as an “essential tool” within the struggle in opposition to Covid-19, hours after Denmark mentioned it was stopping its use, additionally over uncommon incidents of clots in individuals who acquired the vaccine.
That plan seemed to be in jeopardy after Johnson & Johnson mentioned Tuesday it will delay rollout of the vaccine in Europe after it was suspended within the US.
But Attal mentioned the federal government had acquired a primary supply of 200,00zero doses, which “arrived on our territory at the start of the week and are being delivered to GPs and pharmacies”.
His remarks got here as EU chief Ursula von der Leyen warned the bloc was turning extra closely to BioNTech/Pfizer to make up for suspended Johnson & Johnson vaccine doses and for the long run.
Her remarks got here as increasingly EU nations restrict the usage of the adenovirus-type vaccines produced by AstraZeneca and Johnson & Johnson to older folks, who’ve but to be affected by the clotting subject.
Denmark on Wednesday turned the primary EU nation to desert the AstraZeneca vaccine altogether, regardless of the World Health Organization and European Medicines Agency deeming it secure.
Reacting to the Danish transfer, Attal mentioned: “We believe within the AstraZeneca vaccine as an important instrument within the struggle in opposition to the Covid-19 epidemic.
”It is vital that this vaccine proceed to be deployed. It is a vaccine that’s secure and works.”
Read all of the Latest News and Breaking News right here